A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer
Stopped Trial was terminated to allow sponsors to evaluate the future development of the drug program
Conditions
- Carcinoma
- Ovarian Cancer
- Ovarian Diseases
- Ovarian Neoplasms
Interventions
- BIOLOGICAL: AGS-8M4
- DRUG: Pegylated liposomal doxorubicin (PLD)
- DRUG: gemcitabine
- DRUG: carboplatin
Sponsor
Astellas Pharma Inc
Collaborators